Cite

HARVARD Citation

    Luo, L. et al. (2017). Identification of a potent kinase inhibitor targeting EML4-ALK fusion protein in non-small cell lung cancer. MedChemComm. 8 (10), pp. 1914-1918. [Online]. 
  
Back to record